CYDY Company Profile

CYDY Time & Sales

CYDY Recent News

CYDY Filings

CYDY Financials

CYDY Buy Rating

sean007

07/23/2025 5:43:23 PM

"Beneath the surface"...remains the (1)

KenChowder

07/23/2025 5:29:34 PM

Sherlock, companies who make tender (6)

sjacobs26

07/23/2025 4:41:02 PM

I could be off here, but considering (10)

sherlock57

07/23/2025 3:57:35 PM

Sunray--Imagine the response of the (18)

cardamine

07/23/2025 3:07:08 PM

Wiki even makes a separate section for (2)

cardamine

07/23/2025 2:53:12 PM

yeah there's been the proverbial "blood (1)

sunray3

07/23/2025 1:12:31 PM

Oh, I'm sure as I suspect you are that (7)

twinter11

07/23/2025 12:57:30 PM

"I don't pretend to know the motives (7)

sunray3

07/23/2025 12:07:51 PM

Now mind you, I don't pretend to know (3)

sunray3

07/23/2025 11:11:08 AM

Definitely BS, you're right...the MM (7)

Tprovo

07/23/2025 10:43:31 AM

Gap filled at .28 this AM and so did my (2)

Evil Rabbit

07/23/2025 10:03:41 AM

That premarket action was some BS. 11k (6)

dfwl28

07/23/2025 9:55:10 AM

Side effects of Ipilimumab, also known (4)

ohm20

07/23/2025 4:01:10 AM

Ipilimumab Safety Profile: Associated (16)

ohm20

07/23/2025 3:50:15 AM

Based on above hypothesis, It could (11)

KenChowder

07/23/2025 3:13:18 AM

MGK wrote: Based on above hypothesis, (11)

ohm20

07/23/2025 2:56:21 AM

Sorry Ohm, I'm not smart enough to (13)

USS JOHNSTON

07/22/2025 11:27:56 PM

I am also not a doctor, biloxi, so I (5)

MGK_2

07/22/2025 8:09:36 PM

I wrote (4)

biloxiblues

07/22/2025 7:37:02 PM

I am not a Doctor, but this is (4)

craigakess

07/22/2025 7:24:09 PM

Thanks for posting the response. (5)

Mr3Putt

07/22/2025 7:05:07 PM

UWS responds to you at r/Livimmune: (3)

SeeWhyDY

07/22/2025 5:49:35 PM

Am I reading this article (2)

skezan

07/22/2025 4:42:55 PM

Sorry Ohm, I'm not smart enough to (2)

ohm20

07/22/2025 3:34:27 PM

Ipilimumab is an antibody that binds to (10)

craigakess

07/22/2025 1:50:53 PM

Thanks for posting that as it is quite (6)

craigakess

07/22/2025 1:36:36 PM

Strange that it says the study was (2)

sean007

07/22/2025 1:34:19 PM

Europe Not entire (1)

Boatbuilder

07/22/2025 1:15:30 PM

Unfortunately not CYDY. (2)

docj

07/22/2025 12:28:38 PM

Good to see your post. It has been a

KenChowder

07/22/2025 11:16:35 AM

Another poster corrected me on the time (4)

Mr3Putt

07/22/2025 10:44:56 AM

The Jun 24 PR stated that the company (8)

sunray3

07/22/2025 10:36:07 AM

Well, I must admit that's a compelling (11)

Jake2212

07/22/2025 9:25:56 AM

sunray: Sounds good, but keep in mind. (10)

hoops

07/22/2025 9:23:24 AM

There is hope. (3)

KenChowder

07/22/2025 9:15:17 AM

Yes, that Reddit post is worth a read. (12)

sunray3

07/22/2025 9:05:38 AM

Agree, and as you say the acquirer must (11)

sherlock57

07/22/2025 4:42:15 AM

Thanks, 3Putt, for posting that. It's (22)

Mr3Putt

07/21/2025 10:31:35 PM

Require reading for the frustrated (14)

Ramjet

07/21/2025 8:24:56 PM

Agreed, months and years. I feel for (11)

sean007

07/21/2025 7:36:01 PM

"There is no crying in (2)

ohm20

07/21/2025 5:38:01 PM

Unfortunately, the ESMO presentations (20)

biloxiblues

07/21/2025 3:10:55 PM

This is an interesting read on Cytodyn (4)

Tprovo

07/21/2025 2:38:41 PM

I was expecting we would get a shove (2)

Niele

07/21/2025 2:36:18 PM

When we start bickering ourselves and (18)

sherlock57

07/21/2025 2:24:34 PM

In 2024 Cytodyn published 18 press (25)

Katangolo

07/21/2025 2:08:05 PM

Of all days, Ive never been more (17)

hoops

07/21/2025 12:40:21 PM

Check the bid/ask spread.

hoops

07/21/2025 12:32:18 PM

Theres been unusual volatility over (1)

KenChowder

07/21/2025 12:10:16 PM

It might not be a bash, but it is no (5)

Newer

Older

Recent Articles

• Chevron Prepares to Announce Q3 Financial Results Soon
• Exciting Tesla Cybercab Prototype: Steering Wheel Surfaces
• China Leads the Way in Urban Health amidst Climate Challenges
• Zoomlion's Vision for Sustainable Smart Cities Worldwide
• Crédit Agricole S.A. Completes Share Repurchase Program Successfully
• Fresnillo Makes Strategic Move to Acquire Probe Gold
• Projected Growth of Genomics Data Analysis Market to 2034
• Nanobiotix Secures Up to $71 Million in Innovative Funding
• Exciting Launch of $PRDT Token Promises Revenue Sharing Rewards
• Michael Burry's Caution: Avoiding Market Bubbles in 2025
• Rep. Marjorie Taylor Greene Increases Investment in Tech Stocks
• AB Artea Bankas Receives Updated Capital Requirements from ECB
• Mohamed El-Erian Analyzes AI Market: Cautiously Optimistic
• Bekaert's Share Buyback Program and Liquidity Actions Explained
• Sidetrade Partners with NX to Enhance CFO Agility and Growth
• Top Stock Performers: Insights on Major Market Movers
• Facephi Shows Strong Financial Performance and Future Growth
• Kalmar Reports Strong Q3 2025: Profitability and Success in Services
• Loomis Achieves Remarkable Performance in Recent Quarter
• Analyzing Investor Sentiment: Nasdaq's Recent Performance Trends
• Exxon Mobil's Q3 Earnings Preview: Analyst Predictions and Insights
• DXS International's Annual Report: Key Insights and Financials
• Digitalist Group's Third Quarter Review Highlights 2025 Results
• Strong Q3 Results Highlight Growth and Stability for WEHB
• NB Private Equity Partners Effectively Executes Share Buyback
• ICG Enterprise Trust plc Makes Strategic Share Buyback Move
• Understanding the Voting Rights of Northern Venture Trust PLC
• Nanobiotix Partners with Healthcare Royalty for $71 Million Deal
• Fresnillo Enters Agreement to Purchase Probe Gold for C$780M
• Understanding Voting Rights at Northern 2 VCT PLC
• Notable Growth for INVL Technology in 2025 Financials
• Understanding the Latest Net Asset Value of INVL Technology
• Nxera Pharma's Vision Unveiled at Upcoming London Healthcare Conference
• Bioretec Ltd Adjusts H1 Report: Financial Highlights and Outlook
• Tetragon Financial Group Reveals September 2025 Insights
• Bioretec Ltd Updates Financial Report Details for 2025
• Loomis Reports Robust Performance in Q3 2025 with Growth
• Investments from Optiver and Qube Strengthen McKay Brothers
• Strategic Investments by Optiver and QRT Propel McKay Brothers
• Mycenax Partners with RIN Institute to Transform ADC Technology
• Transforming Enterprises: FastGPT's No-code AI Solutions for 2025
• Corbus Pharmaceuticals Moves Forward with Public Offering
• S&P 500 Achieves Historic Winning Streak and Market Insights
• Key Challenges Highlighted by Michael Saylor for Growth Strategy
• Ecer.com Launches Innovative AI Marketplace Strategy for Trade
• Bioretec Ltd Revises 2025 Half-Year Report with Key Updates
• DigitalXForce Achieves Prestigious Leader Status in IDC Assessment
• Danske Bank Sees Positive Trends and Growth for 2025
• Sampo plc's Latest Share Buyback Program and Results
• Exciting Developments in Kudu Well Appraisal by BW Energy